StonvexLoading…
StonvexStonvexStonvexCore line items from INGM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-27 | Annual 2024 2024-12-28 | Annual 2024 2024-09-28 | Annual 2024 2024-06-29 |
|---|---|---|---|---|
Revenue | $52.56B | $47.98B | $11.76B | $11.54B |
Operating Income | $876.93M | $817.92M | $218.17M | $181.13M |
Net Income | $327.88M | $264.22M | $76.97M | $54.59M |
EPS (Diluted) | $1.39 | $1.18 | $0.35 | $0.25 |
Total Assets | $21.24B | $18.78B | Not available | Not available |
Total Liabilities | $17.00B | $15.05B | Not available | Not available |
Cash & Equivalents | $1.86B | $918.40M | Not available | Not available |
Free Cash Flow OCF − CapEx | $785.37M | $191.14M | Not available | Not available |
Shares Outstanding | 235.07M | 234.83M | Not available | Not available |